WHY IT MATTERS: Veterans currently using cannabis or pursuing psychedelic therapy outside the VA system risk losing continuity of care, benefits eligibility concerns, and lack of clinical supervision that a formal federal program would provide. CLINICAL OVERVIEW: Veterans organizations are pressing Congress to broaden access to both cannabis and psychedelic-assisted therapies through the VA system as a response to the persistently high suicide rate among veterans. The push reflects growing clinical evidence that current pharmacological and psychological treatment options are failing a significant portion of this population, particularly those with treatment-resistant PTSD and co-occurring substance use disorders.